NASDAQ:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis $4.27 +0.24 (+5.96%) Closing price 04:00 PM EasternExtended Trading$4.21 -0.06 (-1.41%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Aurora Cannabis Stock (NASDAQ:ACB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aurora Cannabis alerts:Sign Up Key Stats Today's Range$4.03▼$4.2950-Day Range$2.58▼$4.0552-Week Range$2.56▼$6.66Volume1.40 million shsAverage Volume1.12 million shsMarket Capitalization$276.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Aurora Cannabis Inc. is a Canadian cannabis company focused primarily on the production, distribution and sale of medical cannabis products. The company offers products such as dried cannabis flower, pre-rolls, oils, capsules and other cannabis formats through medical and adult-use channels, depending on the applicable market. Aurora markets products under brands including Aurora, MedReleaf and CanniMed. Its business also includes cannabis cultivation, product development, processing and distribution, supported by cultivation and production facilities in Canada and international operations. Founded in 2013 and headquartered in Edmonton, Alberta, Aurora serves customers in Canada and selected international markets, including parts of Europe and Australia. The company has historically emphasized its medical cannabis business and international medical markets. Aurora Cannabis is led by Chief Executive Officer Miguel Martin.AI Generated. May Contain Errors. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 20% of companies evaluated by MarketBeat, and ranked 805th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingModerate Buy Consensus RatingAurora Cannabis has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAurora Cannabis has only been the subject of 3 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aurora Cannabis are expected to grow in the coming year, from ($0.07) to $0.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aurora Cannabis' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.28% of the float of Aurora Cannabis has been sold short.Short Interest Ratio / Days to CoverAurora Cannabis has a short interest ratio ("days to cover") of 5.52.Change versus previous monthShort interest in Aurora Cannabis has recently increased by 0.41%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. News and Social Media1.4 / 5News Sentiment0.22 News SentimentAurora Cannabis has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is a decrease of -30% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of Aurora Cannabis is held by insiders.Percentage Held by Institutions47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACB Stock News HeadlinesAurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and BeyondSeptember 16, 2026 | finance.yahoo.comAurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and BeyondSeptember 16, 2026 | prnewswire.comCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial technology framework in US history. JPMorgan, Citi, Bank of America and Wells Fargo are building a shared next generation payment network targeting 2027, and the DTCC just completed its first live production trades on the new system. Senior analyst Andy Howard breaks down the asset at the center of this shift in a free report.September 22 at 1:00 AM | Awesomely (Ad)Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid (ACB)Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis reforms.September 15, 2026 | marketbeat.comCuraleaf Sends Letter to Aurora ShareholdersSeptember 15, 2026 | finance.yahoo.comAurora Cannabis Says Curaleaf's Attempt to Stop ATM Program is to Distract ShareholdersSeptember 15, 2026 | finance.yahoo.comAurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The FactsSeptember 14, 2026 | finance.yahoo.comAurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The FactsSeptember 14, 2026 | prnewswire.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at $4.22 at the beginning of the year. Since then, ACB shares have increased by 0.1% and is now trading at $4.2260. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (NASDAQ:ACB) announced its earnings results on Wednesday, August, 5th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of ($0.13) by $0.17. The firm earned $47.62 million during the quarter, compared to the consensus estimate of $47.45 million. Aurora Cannabis had a positive trailing twelve-month return on equity of 4.37% and a negative net margin of 32.26%. Read the conference call transcript. When did Aurora Cannabis' stock split? Shares of Aurora Cannabis reverse split on Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Does Aurora Cannabis have any subsidiaries? Aurora Cannabis subsidiaries include Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more. Who are Aurora Cannabis' major shareholders? Aurora Cannabis' top institutional investors include Tidal Investments LLC (1.95%), State of Wyoming (0.03%), Squarepoint Ops LLC (0.03%) and Two Sigma Securities LLC (0.02%). How do I buy shares of Aurora Cannabis? Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), American Water Works (AWK). Company Calendar Last Earnings8/05/2026Today9/22/2026Next Earnings (Estimated)11/04/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (7m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 ACB's financial health is in the Red zone, according to TradeSmith. ACB has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ACB Previous SymbolNYSE:ACB CIK1683541 Webauroramj.com Phone(604) 362-5207FaxN/AEmployees1,028Year Founded2006Profitability EPS (Trailing Twelve Months)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$88.13 million Net Margins-32.26% Pretax Margin-11.84% Return on Equity4.37% Return on Assets3.45% Debt Debt-to-Equity Ratio0.03 Current Ratio5.36 Quick Ratio2.80 Sales & Book Value Annual Sales$247.82 million Price / Sales1.12 Cash Flow$0.77 per share Price / Cash Flow5.51 Book Value$6.27 per share Price / Book0.68Miscellaneous Outstanding Shares64,840,000Free Float64,836,000Market Cap$276.87 million OptionableOptionable Beta0.63 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:ACB) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | Sponsored“Elon Is Not Showing This Publicly, But I Saw It”Elon Musk quietly filed a patent for a new AI invention while attention focused on the SpaceX IPO. Jeff Brown,...Brownstone Research | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACB Stock Alerts